Immunic Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Immunic
IMUX Stock  USD 0.78  0  0.63%   
Immunic's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Immunic's valuation are provided below:
Market Capitalization
93.6 M
Earnings Share
(0.94)
We have found one hundred twenty available fundamental trends for Immunic, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to confirm all of Immunic regular market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 48.7 M in 2025. Enterprise Value is likely to rise to about (66.2 M) in 2025
Check Immunic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immunic's main balance sheet or income statement drivers, such as Depreciation And Amortization of 127.3 K, Interest Expense of 730.2 K or Other Operating Expenses of 61.2 M, as well as many indicators such as Price To Sales Ratio of 17.3 K, Dividend Yield of 0.0064 or PTB Ratio of 5.71. Immunic financial statements analysis is a perfect complement when working with Immunic Valuation or Volatility modules.
  
Build AI portfolio with Immunic Stock
Check out the analysis of Immunic Correlation against competitors.
For more information on how to buy Immunic Stock please use our How to Invest in Immunic guide.

Immunic Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets78.7 M40.9 M67.6 M
Slightly volatile
Short and Long Term Debt Total953.8 K1 M16.8 M
Slightly volatile
Other Current Liabilities7.2 M13.6 M6.2 M
Slightly volatile
Total Current Liabilities23.3 M22.2 M9.7 M
Slightly volatile
Property Plant And Equipment Net1.4 M1.5 M1.7 M
Pretty Stable
Accounts Payable8.2 M7.8 M2.7 M
Slightly volatile
Cash62.2 M35.7 M53.4 M
Slightly volatile
Non Current Assets Total1.5 M1.5 M8 M
Pretty Stable
Cash And Short Term Investments64.1 M35.7 M55 M
Slightly volatile
Common Stock Shares Outstanding105.2 M100.2 M20.8 M
Slightly volatile
Liabilities And Stockholders Equity78.7 M40.9 M67.6 M
Slightly volatile
Non Current Liabilities Total250.8 K264 K8.8 M
Slightly volatile
Other Current Assets3.9 M3 M3.4 M
Slightly volatile
Other Stockholder Equity293.8 M525.6 M252.6 M
Slightly volatile
Total Liabilities12.4 M22.4 M17.8 M
Slightly volatile
Property Plant And Equipment Gross1.4 M1.5 M1.7 M
Pretty Stable
Total Current Assets68.9 M39.3 M59.1 M
Slightly volatile
Common Stock Total Equity3 K4.6 K2.6 K
Slightly volatile
Common Stock8.4 K8 K3.1 K
Slightly volatile
Net Tangible Assets80.6 M130.7 M85.9 M
Pretty Stable
Capital Surpluse326.3 M492.1 M306.8 M
Slightly volatile
Non Current Liabilities Other1.2 M1.1 M475.7 K
Slightly volatile
Property Plant Equipment251.4 K264.6 K1.7 M
Slightly volatile
Net Receivables724.4 K684 K589.6 K
Pretty Stable
Intangible Assets23 M37.9 M17.7 M
Slightly volatile
Net Invested Capital17.5 M18.4 M58.5 M
Very volatile
Net Working Capital16.3 M17.2 M50.8 M
Very volatile
Capital Stock4.1 K8 K3.9 K
Pretty Stable
Capital Lease Obligations1 M1 M712.9 K
Slightly volatile

Immunic Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization127.3 K134 K577 K
Slightly volatile
Other Operating Expenses61.2 M98.1 M53 M
Slightly volatile
Research Development44.2 M80 M38.3 M
Slightly volatile
Total Operating Expenses61.2 M98.1 M53 M
Slightly volatile
Selling General Administrative14.5 M18 M12.6 M
Slightly volatile
Preferred Stock And Other Adjustments7.3 M8.2 M9 M
Slightly volatile
Interest Income3.6 M3.4 M818.7 K
Slightly volatile
Cost Of Revenue227 K134 K606.5 K
Slightly volatile
Net Interest Income3.6 M3.4 M903.5 K
Slightly volatile
Reconciled Depreciation222.1 K134 K589.3 K
Slightly volatile
Selling And Marketing Expenses88.8 K99.9 K108.9 K
Slightly volatile

Immunic Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation4.7 M8.5 M4.1 M
Slightly volatile
Begin Period Cash Flow59.4 M46.7 M51 M
Slightly volatile
Depreciation127.3 K134 K621.5 K
Slightly volatile
Capital Expenditures475.9 K264 K551.4 K
Pretty Stable
Total Cash From Financing Activities52.6 M74.5 M45.6 M
Slightly volatile
End Period Cash Flow62.2 M35.7 M53.4 M
Slightly volatile
Sale Purchase Of Stock73.2 K77 K49.8 M
Slightly volatile
Change To Netincome55.1 M52.5 M16.1 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio17.3 K19.5 K21.2 K
Slightly volatile
Dividend Yield0.00640.00720.0078
Slightly volatile
Stock Based Compensation To Revenue593667727
Slightly volatile
Capex To Depreciation1.11.97011.2709
Slightly volatile
EV To Sales9.7 K10.9 K11.9 K
Slightly volatile
Payables Turnover0.01620.01710.6236
Slightly volatile
Sales General And Administrative To Revenue1.4 K1.6 K1.7 K
Slightly volatile
Research And Ddevelopement To Revenue3.8 K4.3 K4.7 K
Slightly volatile
Capex To Revenue70.4379.2486.3917
Slightly volatile
Cash Per Share0.340.3561288
Slightly volatile
Days Payables Outstanding10.7 K21.4 K9.2 K
Slightly volatile
Income Quality1.020.84340.9592
Slightly volatile
Intangibles To Total Assets0.20.210.1972
Slightly volatile
Current Ratio1.691.77376.9589
Very volatile
Capex Per Share0.00250.00268.3973
Slightly volatile
Revenue Per Share0.00640.00720.0079
Slightly volatile
Interest Debt Per Share0.00950.01102
Slightly volatile
Debt To Assets0.02330.02461.1266
Slightly volatile
Days Of Payables Outstanding10.7 K21.4 K9.2 K
Slightly volatile
Ebt Per Ebit0.751.0250.913
Slightly volatile
Quick Ratio1.691.77376.9522
Very volatile
Net Income Per E B T0.80.90.9789
Slightly volatile
Cash Ratio1.531.60855.9787
Very volatile
Free Cash Flow Operating Cash Flow Ratio1.121.00311.0217
Pretty Stable
Fixed Asset Turnover0.0020.00230.0025
Slightly volatile
Debt Ratio0.02330.02461.1266
Slightly volatile
Price Sales Ratio17.3 K19.5 K21.2 K
Slightly volatile
Asset Turnover1.0E-41.0E-41.0E-4
Slightly volatile

Immunic Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap48.7 M51.2 M250.9 M
Slightly volatile

Immunic Fundamental Market Drivers

Cash And Short Term Investments35.7 M

Immunic Upcoming Events

22nd of February 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Immunic Financial Statements

Immunic investors use historical fundamental indicators, such as Immunic's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Immunic. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue7.7 M8 M
Cost Of Revenue134 K227 K
Stock Based Compensation To Revenue 666.69  592.61 
Sales General And Administrative To Revenue1.6 K1.4 K
Research And Ddevelopement To Revenue4.3 K3.8 K
Capex To Revenue 79.24  70.43 
Revenue Per Share 0.01  0.01 
Ebit Per Revenue-5.9 K-6.2 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
GMGeneral Motors
SSentinelOne
FFord Motor

Additional Tools for Immunic Stock Analysis

When running Immunic's price analysis, check to measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to predict the probability of Immunic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY